Exousia Bio annual gross margin
2024
2025
Exousia Bio Gross Margin Growth & History (LMMY)
Exousia Bio's gross margin was −93.36% for fiscal 2025.
View full Exousia Bio company overviewExousia Bio annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-05-31 | −93.36% | −109.30 pp |
| 2024 | 2024-05-31 | 15.94% | — |
Exousia Bio quarterly gross margin
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2024-08-31 | 100.00% | — |
| Q4 2024 | 2024-05-31 | −157.79% | — |
| Q3 2024 | 2024-02-29 | 100.00% | — |
| Q2 2024 | 2023-11-30 | 100.00% | — |
Exousia Bio gross margin trends
Between the periods ended 2024-05-31 and 2025-05-31, Exousia Bio's gross margin decreased from 15.94% to −93.36%, a change of −109.30 percentage points. The latest reported quarter, Q1 2025, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Exousia Bio source filings ↗